Main Article Content
Vaccine, Acceptance, COVID-19, Iraq
COVID19 emerged as one of the biggest global public health crises in recent history. Many pharmaceutical companies have raced against time to develop a vaccine, so that the pandemic can be brought under control. The aim of the current study was to assess the acceptance of the COVID19 vaccine among the general population in Iraq. A cross-sectional study was conducted among 1069 respondents from different states of Iraq using questionnaires administered online. Though a total of 77.6% of the respondents agreed to take the COVID19 vaccine when available, a majority (64.3%) said they would wait for some time before taking the vaccine. Around two-thirds agreed to pay a price for the vaccine and the majority (48.6%) preferred the Oxford (AstraZeneca) vaccine. There was a significant association between age, working status, educational level, having family members infected with COVID19 and taking flu vaccine before with acceptance of Covid19 vaccine with P value (<0.001, <0.001, <0.001,0.05, <0.001) respectively. Overall, there is high acceptance willingness among the general population to pay for COVID19 vaccine, once it is available. More education and promotion are needed to assure the public that the vaccine is effective and safe
2. Ahn D-G, Shin H-J, Kim M-H, Lee S, Kim H-S, Myoung J, et al. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). J Microbiol Biotechnol. Korea (South); 2020;30:313–24.
3. Ghazi HF, Taher TMJ, AbdalQader MA, Raheema RH, Baobaid MF, Hasan TN. Knowledge, Attitude, and Practice Regarding Disease-19 : Population-Based Study in Iraq Coronavirus. Open Access Maced J Med Sci. 2020;8.
4. Shi Y, Wang G, Cai X-P, Deng J-W, Zheng L, Zhu H-H, et al. An overview of COVID-19. J Zhejiang Univ Sci B. 2020;21:343–60.
5. Zhou M-Y, Xie X-L, Peng Y-G, Wu M-J, Deng X-Z, Wu Y, et al. From SARS to COVID-19: What we have learned about children infected with COVID-19. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2020;96:710–4.
6. AminJafari A, Ghasemi S. The possible of immunotherapy for COVID-19: A systematic review. Int Immunopharmacol. 2020;83:106455.
7. Wang J, Peng Y, Xu H, Cui Z, Williams RO. The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation. AAPS PharmSciTech. AAPS PharmSciTech; 2020;21.
8. Shin MD, Shukla S, Chung YH, Beiss V, Chan SK, Ortega-Rivera OA, et al. COVID-19 vaccine development and a potential nanomaterial path forward. Nat Nanotechnol. England; 2020;15:646–55.
9. Kaur SP, Gupta V. COVID-19 Vaccine: A comprehensive status report. Virus Res [Internet]. Elsevier B.V.; 2020;288:198114. Available from: https://doi.org/10.1016/j.virusres.2020.198114
10. Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495.
11. Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, et al. Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia. Front public Heal. 2020;8:381.
12. Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, et al. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines. Switzerland; 2020;8.
13. COVID-19 outbreak in Baghdad, Iraq very alarming | MSF [Internet]. Médecins Sans Frontières (MSF) International. 2020 [cited 11 October 2020]. Available from: https://www.msf.org/covid-19-outbreak-baghdad-iraq-very-alarming
14. COVID-19 Information | U.S. Embassy & Consulates in Iraq [Internet]. U.S. Embassy & Consulates in Iraq. 2020 [cited 11 October 2020]. Available from:
15. Fontanet A, Cauchemez S. COVID-19 herd immunity: where are we? Nature Reviews Immunology. 2020;20(10):583-584.
16. Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll M et al. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines. 2020;8(3):482.
17.Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, et al. Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia. Frontiers in Public Health. 2020;8(381).
18.Padhi BK, Almohaithef MA. Determinants of COVID-19 vaccine acceptance
in Saudi Arabia: a web-based national survey. medRxiv [Preprint]. (2020).
19.Fisher K, Bloomstone S, Walder J, Crawford S, Fouayzi H, Mazor K. Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults. Annals of Internal Medicine. 2020.
20.Improving vaccination demand and addressing hesitancy [Internet]. World Health Organization. 2020 [cited 13 October 2020]. Available from: https://www.who.int/immunization/programmes_systems/vaccine_hesitancy/en/
21.Olorunsaiye C, Langhamer M, Wallace A, Watkins M. Missed opportunities and barriers for vaccination: a descriptive analysis of private and public health facilities in four African countries. Pan African Medical Journal. 2017;27.
22. Larson HJ, Jarrett C, Eckersberger E, Smith, DMD, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature. Vaccine 2014, 32, 2150–2159. [CrossRef]
23. Yaqub O, Castle-Clarke S, Sevdalis N, Chataway J. Attitudes to vaccination: A critical review. Soc. Sci. Med.2014, 112, 1–11. [CrossRef]
24. Dubé E, MacDonald NE. Vaccine Acceptance: Barriers, Perceived Risks, Benefits, and Irrational Beliefs. In The Vaccine Book, 2nd ed.; Bloom, B.R., Lambert, P., Eds.; Academic Press: Cambridge, MA, USA, 2016; Chapter 26; pp. 507–528.
25.Malik A, McFadden S, Elharake J, Omer S. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020; 26:100495.